Key result
Pre-metabolic syndrome linked to ~20% lower baroreflex sensitivity, driven by hyperglycemia.
Why the study?
Cardiac autonomic dysfunction is evident in metabolic syndrome, but its status and the contributing metabolic components in pre-metabolic syndrome subjects are not well characterized.
Does pre-metabolic syndrome, and specifically its individual components like hyperglycemia, impair cardiac autonomic modulation in adults?
Cross-Sectional (n=182)
No
Does pre-metabolic syndrome, and specifically its individual components like hyperglycemia, impair cardiac autonomic modulation in adults?
Absolute Event Rate: 14.03% vs 17.43%
p-value: p=0.001
Hyperglycemia is an independent determinant of cardiac autonomic dysfunction in adults with pre-metabolic syndrome, suggesting early intervention may prevent progression to full metabolic syndrome and associated cardiovascular risks.
Hyperglycemia was associated with autonomic dysfunction in pre-MetS; leaves open whether early screening alters outcomes.
Metabolic syndrome (MetS) involves multi-factorial conditions linked to an elevated risk of type 2 diabetes mellitus and cardiovascular disease. Pre-metabolic syndrome (pre-MetS) possesses two MetS components but does not meet the MetS diagnostic criteria. Although cardiac autonomic derangements are evident in MetS, there is little information on their status in pre-MetS subjects. In this study, we sought to examine cardiac autonomic functions in pre-MetS and to determine which MetS component is more responsible for impaired cardiac autonomic functions. A total of 182 subjects were recruited and divided into healthy controls (n=89) and pre-MetS subjects (n=93) based on inclusion and exclusion criteria. We performed biochemical profiles on fasting blood samples to detect pre-MetS. Using standardized protocols, we evaluated anthropometric data, body composition, baroreflex sensitivity (BRS), heart rate variability (HRV), and autonomic function tests (AFTs). We further examined these parameters in pre-MetS subjects for each MetS component. Compared to healthy controls, we observed a significant cardiac autonomic dysfunction (CAD) through reduced BRS, lower overall HRV, and altered AFT parameters in pre-MetS subjects, accompanied by markedly varied anthropometric, clinical and biochemical parameters. Furthermore, all examined BRS, HRV, and AFT parameters exhibited an abnormal trend and significant correlation toward hyperglycemia. This study demonstrates CAD in pre-MetS subjects with reduced BRS, lower overall HRV, and altered AFT parameters. Hyperglycemia was considered an independent determinant of alterations in all the examined BRS, HRV, and AFT parameters. Thus, hyperglycemia may contribute to CAD in pre-MetS subjects before progressing to MetS.
No takes yet. Share an insight, caveat, or question.
Gaur et al. (2022) conducted a cross-sectional in Pre-metabolic syndrome (n=182). Pre-metabolic syndrome vs. Healthy controls was evaluated on Baroreflex sensitivity (BRS) (p=0.001). Pre-metabolic syndrome subjects exhibited significant cardiac autonomic dysfunction, including reduced baroreflex sensitivity (14.03 vs 17.43 ms/mmHg, p=0.001), with hyperglycemia acting as a major independent determinant.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: